Product
Acipimox
3 clinical trials
5 indications
Indication
Type 2 diabetesIndication
Eating DisorderIndication
Bulimia nervosaIndication
Pre-DiabetesClinical trial
Ketones, Muscle Metabolism, and SGLT2 InhibitorsStatus: Recruiting, Estimated PCD: 2026-11-01
Clinical trial
Acipimox Administration Together With Short-Term Exercise Exerts A Co-Feedback of Growth Hormone, Pancreatic Polypeptide, Peptide YY and Leptin on Ghrelin in Young Bulimic Czech Women: A Randomized StudyStatus: , Estimated PCD: 2007-12-16
Clinical trial
Investigating Disturbances in Glucose and Glycogen Dynamics in PrediabetesStatus: Recruiting, Estimated PCD: 2025-07-01